Patents by Inventor Anjali Kusumbe

Anjali Kusumbe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reprogramming bone endothelial cells for use in bone angiogenesis and osteogenesis
    Patent number: 10053668
    Abstract: The present invention relates to a factor for reprogramming bone endothelial cells to promote bone angiogenesis and osteogenesis as well as to an ex vivo method for reprogramming a bone endothelial cell to achieve cells able to mediate bone angiogenesis and osteogenesis. The subtype of bone endothelial cells mediating bone angiogenesis and osteogenesis express CD31 and Endomucin as markers.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: August 21, 2018
    Assignee: Max-Planck-Gesellschaft zur Föderung der Wissenschaften e.V.
    Inventors: Ralf H. Adams, Anjali Kusumbe, Saravana Ramasamy
  • REPROGRAMMING BONE ENDOTHELIAL CELLS FOR USE IN BONE ANGIOGENESIS AND OSTEOGENESIS
    Publication number: 20160257934
    Abstract: The present invention relates to a factor for reprogramming bone endothelial cells to promote bone angiogenesis and osteogenesis as well as to an ex vivo method for reprogramming a bone endothelial cell to achieve cells able to mediate bone angiogenesis and osteogenesis. The subtype of bone endothelial cells mediating bone angiogenesis and osteogenesis express CD31 and Endomucin as markers.
    Type: Application
    Filed: October 14, 2014
    Publication date: September 8, 2016
    Inventors: Ralf H. Adams, Anjali Kusumbe, Saravana Ramasamy